Leman Biotech
Leman Biotech is an AI-enabled metabolic cancer immunotherapy founded in 2021.
1
Funding Rounds
$7.0m
Money raised
Overview
Leman Biotech is an AI-enabled metabolic cancer immunotherapy founded in 2021.
-
Websites:
- Business model: B2C
- Headquarters: Lausanne
- Social accounts:
Funding series
Funding Series Analysis
The company Leman Biotech has raised a total of $7m in funding over 1 rounds.
Key Insights:
- Leman Biotech June 2024 Seed Funding Round: $7m
Leman Biotech June 2024 Seed Funding Round
$7m
Industries
Leman Biotech is active in the following industries: